Perspectives from those who live it every day.
The Colorectal Cancer Research Center of Excellence researchers and clinicians are dedicated to finding better ways to prevent and treat colorectal cancer. “We cannot do… Read More »Meet the Colorectal Cancer Research Center of Excellence Campaign Team
October is Breast Cancer Awareness Month. In this episode of the Cancer Matters podcast, Dr Bill Nelson, Director of the Johns Hopkins Kimmel Cancer Center,… Read More »Cancer Matters with Dr. Bill Nelson – The Fetting Fund for Breast Cancer Prevention
The Harry J Duffey Family Patient and Family Services Program at the Johns Hopkins Kimmel Cancer Center has compiled a list of events, activities,… Read More »Living with Cancer Resources and Support – October 2024
In this Cancer Matters podcast, Dr Bill Nelson, Director of the Johns Hopkins Kimmel Cancer Center, talks with Beth Blakey and Samantha Schrager from the Cancer… Read More »Cancer Matters with Dr Bill Nelson – Cancer Hope Network and M.A.P.S
September is Sickle Cell Awareness Month. In this Cancer Matters podcast, Dr Bill Nelson, the Director of the Johns Hopkins Kimmel Cancer Center, speaks to… Read More »Cancer Matters with Dr Bill Nelson – Sickle Cell Awareness Month
In this On Target podcast, Dr Akila Viswanathan, Director of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins Kimmel Cancer Center, speaks with… Read More »On Target with Dr. Akila Viswanathan – Personalized Dose for Seminars in Radiation Oncology
In this On Target podcast, Dr Akila Viswanathan talks with Dr Robert Griffin from the University of Arkansas for Medical Sciences and Dr Chandan Guha… Read More »On Target with Dr Akila Viswanathan – Spatially Fractionated and FLASH Radiotherapy for Seminars in Radiation Oncology
The Harry J Duffey Family Patient and Family Services Program at the Johns Hopkins Kimmel Cancer Center has compiled a list of events, activities, and… Read More »Living with Cancer Resources and Support – September 2024
The FDA has approved a new drug treatment for a type of brain cancer called low-grade glioma. The drug, called vorasidenib, is a targeted cancer… Read More »FDA Approves Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
In this Cancer Matters podcast, Dr Bill Nelson speaks with Robin Hopkins, the author of What Happens Now?, and Dr Tom Smith about how we… Read More »Cancer Matters with Dr Bill Nelson – What Happens Now?